Characteristics of laboratory parameters and morphofunctional parameters of echocardiography of patients with chronic heart failure on the background of chemotherapy for breast cancer in the Republic of Buryatia
https://doi.org/10.25789/YMJ.2025.92.03
Abstract
A cross-sectional study of echocardiographic parameters of the myocardium in patients with chronic heart failure (CHF) undergoing chemotherapy for breast cancer was conducted. The level of C-reactive protein (CRP) was assessed, and possible associations of chemotherapy with echocardiography parameters were evaluated. In the study group, statistically significant associations of CRP were found with such indicators as the blood flow rate in the late diastole caused by atrial contraction, the level of systolic pressure in the pulmonary artery and the left ventricular ejection fraction. Significant differences in these parameters were revealed compared with patients with CHF without cancer.
About the Authors
A. S. Ankudinov
ФГБОУ ВО ИГМУ Минздрава России
Russian Federation
Russian Federation
J. T.-B. Galsanova
ГАУЗ «Городская поликлиника № 6» Минздрава РБ
Russian Federation
Russian Federation
A. L.-N. Zhamyandabayeva
ГАУЗ «Городская поликлиника № 6» Минздрава РБ
Russian Federation
Russian Federation
References
1. Isyangulova A.Z., Khasanov R.S. Cardiotoxicity of breast cancer therapy // Volga Oncological Bulletin. 2020; 3 (43): 72-80.
2. Koltsov A.V., Tyrenko V.V. Experience in the treatment of heart failure as a manifestation of cardiotoxicity of chemotherapy in cancer patients // Effective pharmacotherapy. 2023; 19 (33): 18–22.
3. Rebrova O.Y. Statistical analysis of medical data. Application of the STATISTICA application software package. M.: Mediasphere, 2002. 312 p.
4. Chronic heart failure. Clinical recommendations / Galyavich A.S., Tereshchenko S.N., Uskach T.M. [et al.]. Russian Journal of Cardiology. 2024. No. 29. P. 251-349. doi:10.15829/1560-4071-2024-6162.
5. Attanasio U, Di Sarro E, Tricarico L. Cardiovascular biomarkers in cardio-oncology: antineoplastic drug cardiotoxicity and beyond // Biomolecules. 2024; N 14 (2): 199-215. doi: 10.3390/biom14020199.
6. Avagimyan A, Mkrtchyan L, Abrahomovich O. AC-mode of chemotherapy as a trigger of cardiac syndrome X: а case study. Current Problems in Cardiology // 2022. N 47(9):100994 doi: 10.1016/j.cpcardiol.2021.100994.
7. Edimiris-Herrmann A, Kolberg-Liedtke C, Bittner AK, et al. The role of C-reactive protein as a prognostic biomarker in patients with early breast cancer treated with neoadjuvant chemotherapy. Breast Care (Basel). 2022; 17(4): 371-376. doi: 10.1159/000522606.
8. Jain D, Aronow W. Cardiotoxicity of cancer chemotherapy in clinical practice. Hosp Pract. (1995). 2019. N 47(1): 6-15. doi:10.1080/21548331.2018.1530831.
9. Hart PC, Rajab IM, Alebraheem M, [et al.] C-reactive protein and cancer-diagnostic and therapeutic insights. Front Immunol. 2020. N 11: 595835. doi: 10.3389/fimmu.2020.595835
10. Maio R, Perticone M, Suraci E, et al. Endothelial dysfunction and C-reactive protein predict the incidence of heart failure in hypertensive patients. ESC Heart Fail. 2021; 8(1): 399-407. doi: 10.1002/ehf2.13088
11. Osataphan N, Phrommintikul A, Chattipakorn, S. Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: insights for future interventions. Journal of Cellular and Molecular Medicine 2020. N 24: 6534–6557.
12. Ribeiro ÉCT, Sangali TD, Clausell NO. Am J Cardiol. C-reactive protein and frailty in heart failure. 2022. N (66): 65-71. doi: 10.1016/j.amj-card.2021.11.018.
13. Suter TM, Ewer MS. Cancer drugs and the heart: importance and management // Eur. Heart J. 2013. N 34 (15): 1102-1111.
14. Wu L, Wang L, Du Y, et al. Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity. Trends Pharmacol Sci. 2023; 44(1): 34-49. doi: 10.1016/j.tips.2022.10.003.
15. Zhang Y. Diagnostic value of echocardiography combined with serum C-reactive protein level in chronic heart failure. J Cardiothorac Surg. 2023; 18(1): 94-115. doi: 10.1186/s13019-023-02176-7.
16. Zhou K, Li C, Chen T, et al. C-reactive protein levels could be a prognosis predictor of prostate cancer: a meta-analysis. Front Endocrinol (Lausanne). 2023. N 14 (3): 1111277. doi: 10.3389/fendo.2023.1111277.
Review
For citations:
Ankudinov A.S., Galsanova J.T., Zhamyandabayeva A.L. Characteristics of laboratory parameters and morphofunctional parameters of echocardiography of patients with chronic heart failure on the background of chemotherapy for breast cancer in the Republic of Buryatia. Yakut Medical Journal. 2025;(4):17-21. (In Russ.) https://doi.org/10.25789/YMJ.2025.92.03
Views:
31
JATS XML
Email this article 